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For many general surgical procedures, quality of care does not differ greatly between 
providers or hospitals. However, the outcomes of complex surgical procedures such as 
those performed on the liver or pancreas have been shown to vary by hospital, surgeon and 
their respective volume or experience.  
 
This research sought to provide an assessment of the current state of hepatic and pancreas 
surgery in Australia with identification of potential areas for improvement. A systematic 
search for studies investigating the determinants of mortality and morbidity for hepatic 
resection and pancreaticoduodenectomy (PD) was performed. A particular focus on 
Australian studies revealed gaps in the current available evidence.  
 
The first objective was to evaluate the mortality due to hepatic resection in Australia. 
Publication 1 (Variability of perioperative mortality of hepatic resection in Australia) 
reflected this aim. Australian Institute of Health and Welfare (AIHW) data was 
interrogated for hepatic resection. The overall POMR for hepatic resection in Australia was 
1.6% with significant interstate variability but without significant variability over time.  
 
Publications 2 (Peer review of mortality after pancreaticoduodenectomy in Australia) and 3 
(Peer review of mortality after hepatectomy in Australia) used the data collected from the 
Australian and New Zealand Audit of Surgical Mortality (ANZASM) to examine the 
factors leading to mortality post hepatic or pancreas resection. This was a unique approach 
not previously employed to examine the drivers of mortality for a specific procedure. For 
each patient death following PD or hepatic resection, the ANZASM Assessor’s 
determination of whether patient care could have been improved was reviewed and 
summarised using thematic analysis. ANZASM assessors determined that a poor decision 
to operate contributed to 17% of deaths post PD and 25% of deaths post hepatic resection. 
Delay in the recognition of serious complication was considered relevant in 21% and 18% 
of PD and hepatic resection deaths respectively. Multi-disciplinary decision making has 
been strongly recommended in deciding which patients to offer these complex procedures. 
Optimal care includes early recognition of complications and enactment of an adequate 
rescue plan.  
 
Finally, mortality data from the Victorian Admitted Episodes Database was interrogated 
for patients who underwent PD in public hospitals and reported in publication 4 (The 
short-term outcomes of pancreaticoduodenectomy in the state of Victoria – Hospital 
resources are more important than volume). Risk adjusted perioperative outcomes were 
reported and compared for hospital volume and hospital peer group. The overall inpatient 
mortality for PD in Victoria was 2.7% with a significant difference in mortality between 
hospital peer groups and not hospital volume. This finding highlights the importance of 
resource availability in the care of these complex patients.  
 
The results seen in this group of studies contribute new evidence into the current status and 
variability of hepatic and pancreatic surgery in Australia. Furthermore, the two studies 
investigating the determinants of perioperative mortality provide a new perspective to the 
current international literature on hepatobiliary surgery.   
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Abstract
Background: Hepatic resection is a relatively young and complex specialized procedure.
A strong relationship between volume and perioperative mortality has been reported interna-
tionally. However, there has been no multicentre study into hepatic resection in Australia.
This retrospective, population-based cohort study was conducted to determine national, state
and territory based volume and perioperative mortality rates (POMRs).
Methods: Australian Institute of Health and Welfare data was interrogated for the
Australian Classification of Health Intervention codes for hepatic resection defined as
extended hemi-hepatectomy (30421), hemi-hepatectomy (30418), segmental hepatic re-
section (30415) and sub-segmental hepatic resection (30414). Logistic regression analysis
was performed using the de-identified data to investigate trends and differences between
states/territories. Mortality rates were risk adjusted for age, gender and public or private
admission. The data set included patients who underwent hepatic resection in the financial
years 2005/2006 to 2012/2013.
Results: The overall POMR for all types of hepatic resection was 1.6% (201/12 562).
There was no significant change in POMR over time. However, there was significant varia-
tion between the states and territories with two states having significantly higher POMR for
major hepatic resections (regional range: 1.3–3.8%). POMRs increased with age with the
highest mortality seen in the 75–79 year age group. The POMR was lower in private than
in public hospitals.
Conclusion: The results of this study confirm that the overall Australian POMR for major
hepatic resection is similar to results reported internationally. National and state/territory
POMR has not varied significantly over time. The significant variation between states/terri-
tories warrants further investigation.
Introduction
For many general surgical procedures, quality of care does not dif-
fer significantly between providers or hospitals. However, the out-
comes of complex surgical procedures such as those performed on
the liver, pancreas or oesophagus have been shown to vary by hos-
pital, surgeon and their respective volume of experience.1,2
Australia is relatively unique with its widely dispersed popula-
tion. One-third of Australia’s population live outside of a major
city.3 Centralization of liver resectional surgery has occurred in
many Western countries with consistently good results.4,5 Hepatic
resection in Australia is known to be performed in relatively low-
volume centres. The relationship between volume and outcome
shown in the literature may represent the quality of care provided
and not just be a function of throughput.
The perioperative mortality rate (POMR) is an indicator of access
to and safety of surgery and the associated anaesthesia for a defined
procedure. POMR is used as a tool to evaluate care at a population
level and should be risk-adjusted to compare jurisdictions. The
POMR is measured over a set time period and is expressed as the
number of deaths per procedure.6 The complexities of hepatic re-
section and the associated perioperative care are such that the
POMR of this procedure should provide an adequate but broad
marker of quality of care.
Progressive advances in multiple aspects of hepatic resection have
resulted in improved outcomes.7,8 A recent analysis of greater than
4000 resections for malignant disease in a high-volume centre in
the United States concluded that the trend towards parenchymal
preservation and a consequent reduction in major hepatectomy rates
is the most recent significant factor.9 The authors found an overall
© 2018 Royal Australasian College of SurgeonsANZ J Surg 88 (2018) 1022–1027
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30-day mortality rate of 1% and a 90-day mortality rate of 3%. The
90-day mortality rates associated with extended hepatectomy and
right hemi-hepatectomy for malignant disease were 6% and 3%,
respectively. Perioperative mortality has been reported by other
international studies as between 3% and 3.5%.7,10,11
This retrospective, population-based cohort study was conducted
to determine national, state and territory based volume and POMRs
for hepatic resection. A nationwide study examining hepatic re-
section in Australia will enable comparison across regions and with
the outcomes reported internationally.
Methods
Australian Institute of Health and Welfare data from all admissions to
public and private Australian hospitals from 1 July 2005 to 30 June
2013 was interrogated for the Australian Classification of Health
Intervention codes for the four types of hepatic resection: extended
hemi-hepatectomy (30421), hemi-hepatectomy (30418), segmental re-
section (30415) and sub-segmental resection (30414). Extraction of
data was based upon the first 10 procedural codes and where there
were multiple hepatic resection codes, the most extensive was
recorded. De-identified data included year of operation, age group
(5 year bands), gender, state/territory of admission, private/public
admission and mode of separation (deceased, transferred, discharged
etc). POMR was defined as the number of deaths that occurred during
the same hospital admission as the procedure (including after 30 days)
divided by the total number of admissions for that procedure.
Binary logistic regression models were used to investigate trends
and differences between states/territories. This was performed sepa-
rately for all resections (extended hemi-hepatectomy, hemi-hepatec-
tomy, segmental and sub-segmental hepatic resection) and major
resections (extended hemi-hepatectomy and hemi-hepatectomy).
Patient status was the binary response variable (discharged or
deceased) and predictor variables included year of admission (linear
effect where year 2005/2006 = 0 to 2012/2013 = 7). The model
was run by state/territory and as a nation, with each state/territory
as a predictor variable.
Risk was adjusted by including patient age, gender and private
or public admission in the model. Age was considered as a continu-
ous variable based upon the starting age of each bracketed group
(e.g. 55–59 = 55). The Wald test was used to assess significance of
the model variables with P < 0.05 considered significant. Non-
significant terms were removed stepwise until significant variables
remained.
The procedural admission distribution for the states/territories
was compared to population density at June 2013.12 The distribu-
tion was tested for independence using the chi-square test. POMR
trends for age were reviewed for states with higher POMR to reveal
at-risk age groups; the significance of the findings was tested using
the chi-square test of association.
Results
During the period from 1 July 2005 to 30 June 2013, there were
12 562 hepatic resections performed in Australian hospitals; 5006
(39.9%) of these were major hepatic resections. Figure 1 shows the
number of admissions for all types of hepatic resection and the pro-
portion of major resections by year. There was a 46% increase in
the total number of procedures across the study period. There were
more males than females at 52.9% and 47.1%, respectively. Peak
procedural incidence was in the 65–69 year age group (14.4%).
More procedures were performed in public hospitals (56.3%) than
in private hospitals (42.6%).
The overall POMR for all hepatic resections over the study
period was 1.6% (Table 1). There was no significant change in
POMR over time (P = 0.095). POMRs increased with age (non-
linear effect, P < 0.001), with the highest mortality seen in the
75–79 year age group at 3.9% (39/995) (Fig. 2). POMR was lower
in private versus public hospitals (odds ratio (OR): 0.706, 95% CI:
0.526, 0.949; P = 0.021). The POMR for males was 1.9% and
1.3% for females (OR: 1.608, 95% CI: 1.203, 2.150; P = 0.001).
Fig. 1. Total number of hepatic re-
section admissions and the proportion of
major hepatic resection in Australian hospi-
tals between 1 July 2005 and 30 June
2013. , Minor hepatic resection; , major
hepatic resection.
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Across Australia, there were approximately 25 perioperative deaths
per year following hepatic resection with 16 of these having under-
gone a major resection (Table 2).
The POMR for major hepatic resections was 2.6% (Table 2). As
was the case when including all hepatic resections, examining
major resections separately revealed no significant change in
POMR over time (P = 0.170). POMRs increased with age (non-
linear effect, P < 0.0001) (Fig. 2) and were lower in private versus
public hospitals (OR: 0.583, 95% CI: 0.396, 0.858; P = 0.006).
The POMR for each state and territory are shown in Tables 1
and 2 for all resections and major resections, respectively. There
was a significant POMR variation between the states and territories
(all hepatic resections: P < 0.001, major hepatic resection:
P = 0.001), ranging from 0.6% to 2.5% for all types of hepatic re-
section and 1.3% to 3.8% for major resections.
The procedural admission distribution across the states/territories
showed statistically significant variation. The number of resections
per million population per year for each state or territory is shown
in Table 3.
Both New South Wales (NSW) and Western Australia (WA) had
the highest POMR out of the states/territories for major hepatic re-
section with POMR of 3.77% and 3.80%, respectively. Within
NSW, patients over 60 years of age undergoing major resection had
a mortality rate of 5.4% compared with 2.8% for the rest of the
nation for this age group (P = 0.002). The relatively high POMR in
WA is almost entirely accounted for within the 70–79 year age
group. Across all regions outside of WA, this age group had a
POMR of 5.4%. In WA, the mortality rate of 70–79 year olds was
12% (P = 0.036). No patients over 80 years of age died in the peri-
operative period after major hepatic resection in WA.
Discussion
The results of this study show that Australia’s national hepatic re-
section perioperative mortality compares favourably with that seen
internationally. However, international studies consistently show
evidence of improvement over 5–12 year periods.7,9 Neither the
national nor the state/territory POMRs showed improvement over
the 8 years of the data collection period. This was the case for all
types of hepatic resection and overall. The reason for this may be
that improvements are made less obvious by increasing complexity
of cases and/or an increase in the number of procedures performed
on chemotherapy-affected livers across the study period. However,
this same trend would have been expected to be seen overseas.
While Australian POMRs are reasonable, reasons for our lack of
improvement over time should be further investigated.
There are two strong themes from the available literature on
population-based studies of hepatic resection. The first is the
reported value of centralization and the second around parenchymal
preservation and decreasing major hepatectomy rates to reduce
mortality and morbidity.
The volume effect for hepatic resection was summarized in a
2013 meta-analysis and suggested a strong volume outcome rela-
tionship for mortality. However, while the included studies defined
the cut-off value between high and low as 10–20 resections per
year, low-volume centres were extremely low (1–4 cases per year)
and high-volume centres were between 11 and 63 cases per year.4
The low volumes in this study are very low and any unit doing this
would struggle to maintain proficiency. Considering this, the find-
ing that mortality was twice as high in the low-volume centres
should not be unexpected. In a recent paper out of Italy, Torzilli
et al.13 have produced a good commentary on the ideal centre for
hepatic resection. They describe the inherent variability in the defi-
nition of resectability and the use of a simple volumetric criteria to
define a type of hepatic resection. Torzilli et al.13 have proposed
centralization of hepatic resection in Italy to centres that can main-
tain an operative volume of greater than 20 procedures per year
with <3% 90-day mortality. Centralization has already occurred in
the United Kingdom, United States and Canada. In one state of
Australia, Victoria, there are nine specialist liver surgery units per-
forming between 7 and 40 resections per year (C. L. Stevens,
unpubl. abstract, 2017), volumes that are not dissimilar to those
Table 1 Mortalities, admissions and post-operative mortality rates for hepatic resection (July 2005 to June 2013)
Year NSW VIC QLD WA SA TAS ACT NT AUS
2005/2006 n 11/448 6/252 3/265 1/119 0/111 0/23 1/15 0/2 22/1235
POMR (%) 2.5 2.4 1.1 0.8 0.0 0.0 6.7 0.0 1.8
2006/2007 n 7/510 2/271 7/315 3/159 0/98 0/21 0/25 0/3 19/1402
POMR (%) 1.4 0.7 2.2 1.9 0.0 0.0 0.0 0.0 1.4
2007/2008 n 10/532 4/284 3/306 5/133 1/139 1/24 0/15 0/0 24/1433
POMR (%) 1.9 1.4 1.0 3.8 0.7 4.2 0.0 0.0 1.7
2008/2009 n 16/587 3/294 4/327 3/104 1/165 1/26 1/30 0/3 29/1536
POMR (%) 2.7 1.0 1.2 2.9 0.6 3.8 3.3 0.0 1.9
2009/2010 n 20/638 4/323 5/366 5/111 0/120 1/23 1/33 0/0 36/1614
POMR (%) 3.1 1.2 1.4 4.5 0.0 4.3 3.0 0.0 2.2
2010/2011 n 20/631 2/369 4/347 2/135 2/125 1/31 0/41 0/1 31/1680
POMR (%) 3.2 0.5 1.2 1.5 1.6 3.2 0.0 0.0 1.8
2011/2012 n 10/660 7/455 1/381 1/152 0/133 0/42 0/40 0/0 19/1863
POMR (%) 1.5 1.5 0.3 0.7 0.0 0.0 0.0 0.0 1.0
2012/2013 n 12/610 2/472 2/383 0/119 2/127 0/44 3/44 0/0 21/1799
POMR (%) 2.0 0.4 0.5 0.0 1.6 0.0 6.8 0.0 1.2
Total n 106/4616 30/2720 29/2690 20/1032 6/1018 4/234 6/243 0/9 201/12562
POMR (%) 2.3 1.1 1.1 1.9 0.6 1.7 2.5 0.0 1.6
ACT, Australian Capital Territory; AUS, Australia; NSW, New South Wales; NT, Northern Territory; POMR, perioperative mortality rate; QLD, Queensland; SA,
South Australia; TAS, Tasmania; VIC, Victoria; WA, Western Australia.
© 2018 Royal Australasian College of Surgeons
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Fig. 2. Number of minor and major hepatic resection admissions graphed with perioperative mortality rate (POMR) for Australian hospitals between 1 July
2005 and 30 June 2013. , Major hepatic resection; , minor hepatic resection; , major hepatic resection POMR; , minor hepatic
resection POMR.
Table 2 Mortalities, admissions and post-operative mortality rates for major hepatic resection (July 2005 to June 2013)
NSW VIC QLD WA SA TAS ACT NT AUS
2005/2006 n 10/150 3/96 1/85 1/49 0/29 0/10 0/4 0/0 15/423
POMR (%) 6.7 3.1 1.2 2.0 0.0 0.0 0.0 0.0 3.5
2006/2007 n 4/186 1/111 5/126 2/56 0/40 0/10 0/16 0/0 12/545
POMR (%) 2.2 0.9 4.0 3.6 0.0 0.0 0.0 0.0 2.2
2007/2008 n 5/195 2/107 1/135 4/56 1/48 0/8 0/10 0/0 13/559
POMR (%) 2.6 1.9 0.7 7.1 2.1 0.0 0.0 0.0 2.3
2008/2009 n 11/225 1/134 3/139 2/38 0/65 0/5 0/11 0/0 17/617
POMR (%) 4.9 0.7 2.2 5.3 0.0 0.0 0.0 0.0 2.8
2009/2010 n 12/266 3/146 3/158 3/37 0/55 1/11 1/17 0/0 23/690
POMR (%) 4.5 2.1 1.9 8.1 0.0 9.1 5.9 0.0 3.3
2010/2011 n 12/252 1/150 4/157 2/55 2/49 0/9 0/16 0/0 21/688
POMR (%) 4.8 0.7 2.5 3.6 4.1 0.0 0.0 0.0 3.1
2011/2012 n 7/271 6/197 1/160 0/43 0/50 0/11 0/15 0/0 14/747
POMR (%) 2.6 3.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9
2012/2013 n 7/257 2/199 0/150 0/34 2/62 0/14 2/21 0/0 13/737
POMR (%) 2.7 1.0 0.0 0.0 3.2 0.0 9.5 0.0 1.8
Total n 68/1802 19/1140 18/1110 14/368 5/398 1/78 3/110 0/0 128/5006
POMR (%) 3.8 1.7 1.6 3.8 1.3 1.3 2.7 0.0 2.6
ACT, Australian Capital Territory; AUS, Australia; NSW, New South Wales; NT, Northern Territory; POMR, perioperative mortality rate; QLD, Queensland; SA,
South Australia; TAS, Tasmania; VIC, Victoria; WA, Western Australia.
© 2018 Royal Australasian College of Surgeons
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throughout the nation. If mortality was a proxy for quality of care,
the relatively low volumes and de-centralized nature of liver sur-
gery in Australia are resulting in acceptable care by international
standards. More work needs to be done to determine oncological
performance and long-term survival.
The data collected in this study have revealed that the proportion
of major hepatectomy has remained steady over time at approxi-
mately 40% (Fig. 1). As has been seen overseas, reduction in this
rate through parenchymal preservation would very likely see our
mortality rates improve.7,9 However, the rate found here is only
slightly higher than the Memorial Sloan Kettering major hepatec-
tomy rate through a similar era (2007–2012) at 36%.9
Hepatectomy in octogenarians has been the subject of three rela-
tively small studies with all showing that resection at this age is
safe with good patient selection and recognition of an increased
risk.14–16 Over the 8-year period of this study, there were 648 resec-
tions performed on octogenarians with a mortality of 2.3%
(15/648). While not statistically significant (P = 0.075), the mortal-
ity of the octogenarians was less than the 75–79 age group at 3.9%
(39/995), possibly reflecting more considered patient selection once
the age of 80 was reached.
The good overall results shown here suggest that Australia is per-
forming well by international standards. However, further investi-
gations into the reasons for interstate variability are needed to
confirm that this is truly the case in all regions. The difference
between the best and worst performing states/territories may be due
to case mix and could be a reflection of aggressive versus conserva-
tive behaviour. However, population data does not help explain the
variability in POMR between regions. The numbers of cases per
million population varied by region and there was no relationship
between regional caseload and POMR.
Two states, NSW and WA, had relatively high POMR for major
hepatic resection in comparison to the other states and territories.
For all types of hepatic resection, 53% of the deaths throughout the
study period occurred in patients treated in NSW, where 37% of
the total population was treated. Increasing age was a significant
predictor of poor outcome in NSW overall and patients over
60 years of age undergoing major resection suffered a particularly
high mortality rate. The proportion of extended hepatectomy was
slightly higher for NSW than the other states suggesting that this
state may do more of these more morbid cases. However, this was
not statistically significant and it could also be due to variability in
coding practices. Four NSW hospitals are participating in the
American College of Surgeons National Surgical Quality Improve-
ment Program (NSQIP), the broadening of this participation or
another type of national registry may provide more explanation for
the interstate variability seen in this study.
The relatively high POMR for major hepatic resection seen in
WA is almost entirely accounted for within the 70–79 year age
group where nearly two-thirds of their deaths were seen. It is possi-
ble that good patient selection in octogenarian patients was the rea-
son for the zero POMR in this age group. However, further
investigation is required to determine the reason for the high
POMR for patients in their 70s.
The major limitation of this study is the inability to allow for
case mix adjustment between states and territories. The lack of
detail inherent in using an administrative data set precludes the
authors from commenting definitively on the reason for the inter-
state variability. The difference between the best and worst per-
forming states/territories may be due to case mix and could be a
reflection of aggressive versus conservative behaviour. The num-
bers of cases per million population do not suggest that perfor-
mance is related to proportion of population treated. Data revealing
the relationship between hospital volume and POMR would have
been a valuable addition to this study. However, the de-identified
nature of the data set did not allow this to be derived.
A further limitation of this study is the inability to derive a 90-
day mortality rate from the data set. The quality of hepatic re-
section lies also in the oncological outcomes which are not
recorded at a population level in Australia.
Despite its limitations, the results of this study confirm that
POMR for hepatic resection in Australia is similar to that reported
internationally. The results should drive further investigation into
the quality and variability of hepatic surgery in Australia. The sig-
nificant variation between regions warrants further investigation.
The development of a national registry of hepatic resection data
would enable further study and potentially reveal areas where some
centres excel and others fail, thereby generating overall improve-
ment. In particular, patient selection, the degree of parenchymal
preservation and the use of appropriate rescue where necessary
would significantly affect mortality rates and would only be cap-
tured well by prospective study or a large-scale registry.
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Background: The data within the Australian and New Zealand Audit of Surgical Mortality (ANZASM)
provides a unique opportunity to consider the contributing factors to perioperative deaths as determined
by peer review. Consideration of the factors contributing to mortality after pancreaticoduodenectomy
(PD) can provide greater insight into how deaths can be prevented.
Methods: ANZASM data from 1 January 2010 to 30 Jun 2017 was reviewed and all deaths following PD
were selected for analysis. Assessor’s determination of whether management could have been improved
were reviewed and classified into groups of significant clinical events using thematic analysis with a data
driven approach.
Results: The study included 87 deaths reported to ANZASM after PD. Forty-two major complications
were considered significant clinical events in 29/84 (35%) of patients. The assessor determined that there
was a delay in recognising a significant complication in 18/84 (21%) of patients. In 14/84 (17%) of pa-
tients, ANZASM assessment questioned the decision to operate.
Conclusion: Multi-disciplinary decision making is strongly recommended when deciding which patients
to treat with PD. Late recognition, and therefore delayed action to treat complications, in almost a quarter
of deaths is a significant finding that warrants consideration for clinicians involved in the postoperative
care of PD patients.Received 10 October 2018; accepted 4 March 2019Correspondence
Claire L. Stevens, Discipline of Surgery, University of Adelaide, The Queen Elizabeth Hospital, Australia.
E-mail: Claire.stevens@sa.gov.auIntroduction
The Australian and New Zealand Audit of Surgical Mortality
(ANZASM) is a peer review audit of surgical deaths under the
direction of the Royal Australasian College of Surgeons (RACS).
The objective of the audit is to improve the quality of surgical
practice through information gathering, education and facilita-
tion of change. The audit has been conducted Australia-wide
since 2010 and has collected considerable data on surgeon
identified avoidable issues contributing to in-hospital surgical
deaths. While ANZASM was formed for the purposes of both
nation’s surgical communities, New Zealand does not currently
participate in the ANZASM program. In New Zealand, a* No previous communication to society or meeting.
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reviewing and reporting mortalities with a view to reducing
deaths and enabling continuous quality improvement.
Pancreaticoduodenectomy (PD) is a complex procedure with a
perioperative mortality rate of around 3% in Australia.1,2 For PD,
Australian hospitals have morbidity and mortality results com-
parable to those reported internationally, despite relatively low
volumes.3,4 There have been multiple studies worldwide
reporting the benefits of centralisation, with the reasons given for
the improved results seen in larger centres being related to the
management of major postoperative complications.5,6 However,
additional factors such as multidisciplinary approaches to care
including preoperative planning and decision making, and the
availability of pooled competence, capacity and peer support in
patient care are likely to contribute to better patient outcomes.ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
urgeons from ClinicalKey.com.au by Elsevier on January 01, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
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HPB 1471The ANZASM provides a unique opportunity to investigate
the events leading to the in-hospital mortality post-PD in
Australian hospitals over recent years. This audit enables exam-
ination of the preoperative, intraoperative and postoperative
events leading to each investigated death. The objective of this
study was to determine the reasons for deaths post-PD in
Australia as considered by the reviewers.Methods
ANZASM data and peer review process
The function, governance and objectives of the ANZASM have
been thoroughly described elsewhere.7 However, a synopsis of
the audit process is described here.
Independently of the treating surgeon, ANZASM is notified of
in-hospital surgical deaths (whether there was a surgical pro-
cedure or not) by medical records departments. The hospital
data includes designation of the admission as emergency or
elective, which is determined by whether the admission was due
to a planned procedure listed on a waiting list. Clinical details are
collected via a standardised form completed by the treating
surgeon either online or in paper format. (The ANZASM patient
report form is available at https://www.surgeons.org/media/
25780653/example_racs_generic_scf_non-trauma.pdf).
ANZASM data is stored in an encrypted database that enables a
complete audit trail. The de-identified patient details are sent for
first-line assessment to a surgeon of the same specialty and from
a different hospital. In most cases, conclusions may be reached
about the patient’s care at this point and further investigation is
deemed unnecessary. Alternatively, if further consideration of the
patient’s care is required, a second-line assessment is conducted
by a different surgeon. The second-line assessor reviews the
involved hospital’s patient notes. Second-line assessment has
been undertaken in 12–13% of all patients referred to ANZASM
for the time period examined in this study.8
As a part of the audit process, ANZASM assessors determine
whether there was an aspect of the patient’s management that
could have been better, and feedback is provided to the treating
surgeon. The ANZASM data is held under qualified privilege
which protects the confidentiality of identifying information for
both practitioner and patient.9 This protection enables surgeons
to freely divulge information with confidence that the informa-
tion gathered will be used exclusively for the purposes of pro-
fessional development. Since 2012, 100% of public hospitals, up
to 92% of private hospitals and over 98% of surgeons
participate.8,10
Data analysis
Prospectively collected ANZASM data from 1 January 2010 to 30
Jun 2017 was retrospectively reviewed and deaths following PD
were selected for analysis. Demographics, clinical and treatment
details were gathered from the information submitted by
Australian hospitals and treating surgeons. Assessor’sHPB 2019, 21, 1470–1477 © 2019 International Hepato-P
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improved in the areas of decision to operate, intraoperative and
technical management of surgery and postoperative care were
analysed.
As a part of the audit process, assessors determine significant
clinical events relevant to the patient’s care and classify these into
a level of seriousness. The process is similar for first and second-
line assessment. Where a second-line or patient note assessment
was performed, this was used in the analysis and the first line
assessment disregarded. For all other patients, the first line
assessment findings were included. Assessors annotate whether
each of the clinical events were firstly, a contributing factor in the
death of the patient and secondly, preventable or not. The
determination of preventability, while relevant to each individual
patient, was not considered further here. Preventable and non-
preventable clinical events leading to mortality were all
included in this study as they are useful in the determination of
causes for mortality as an outcome of PD.
Assessor’s clinical issue descriptions were reviewed and clas-
sified into groups of significant clinical events using thematic
analysis with a data driven approach.11 Methods described by
Braun and Clarke were used to develop themes.12 Two re-
searchers (CS and JR) then independently classified the assessor’s
clinical issue descriptions into the relevant themes. Differences
were discussed, and consensus achieved.Results
From January 2010 to June 2017 there were 87 deaths reported to
the ANZASM after PD. Medicare Australia data (which includes
all patients, private and public) recorded 2330 PDs during this
period.13 The cohort of patients represented in the ANZASM
represent 3.7% of this number.
Patient characteristics retrieved from the ANZASM patient
reports are summarised in Table 1. The median age of the pa-
tients was 72 years (49–87 years). Clinically significant infection
was reported in 28/87 (32%) patients. Return to theatre was
reported in 50/87 (58%) patients and included formal radio-
logical intervention such as embolisation.
ANZASM first-line peer review assessment was conducted in
84/87 (97%) of the reported deaths, while 22/84 (26%) went on
to have second-line assessment with full review of the patient’s
hospital documentation. Seventy-two clinically significant events
were described by the assessors in 50 patients, with 22 patients
having two or more events described. Tables documenting pa-
tient outcomes have each patient labelled with an individual
number 1–50 for purposes of tracking. In the remaining 34
patients, there were no assessors’ comments on clinically sig-
nificant events leading to the patient’s mortality. For these 34
patients and the three patients who had no ANZASM assessment,
the data submitted by the treating surgeon was reviewed by the
authors and a summary of that record of events is included as
Supplementary Table 2a (patients 51–84) and 2b (patientsancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
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Table 2 Patients in whom ANZASM Assessor’s determined a flawed d







1 78 Emergency Yes No
2 71 Elective Yes No
3 81 Elective Yes No
4 57 Elective Yes Post-ope
5 52 Elective Yes Delay in r
compli
6 75 Emergency Yes Post-ope
7 63 Elective Yes Vascular
8 71 Elective Yes No
9 73 Elective Yes No
10 85 Emergency Yes No
11 70 Elective Yes Delay in r
compli
12 80 Elective No No
13 55 Emergency Yes No
14 52 Elective No Post-ope
ERCP, endoscopic retrograde cholangiopantography; PTC, percutaneous
Table 1 Summary of patients
Number of
patients (%)
American Society of Anaesthesiologists (ASA) score
ASA 1 3 (3)
ASA 2 34 (39)
ASA 3 44 (51)
ASA 4 4 (5)
Not recorded 3 (3)
Hospital type










Not recorded 1 (1)
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been an adverse event in 14/37 (38%) of these patients.
The clinically significant events as determined by the
ANZASM assessors were grouped into the following themes by
two of the authors:
A. Preoperative
1. decision to operate
B. Intraoperative
1. decision to proceed
2. vascular injury
C. Postoperative
1. delay in recognising complication
2. postoperative haemorrhage
3. anastomotic leak
4. other complicationsOperative decision making
The ANZASM assessment of ‘decision to operate’ as a significant
clinical event was recorded in 14/84 (17%). A summary of the
ANZASM findings for these patients is reported as Table 2.
The ‘decision to proceed’ with the operation after unexpected




Transfer to larger hospital for ERCP should have
been considered instead of PD
Inadequate pre-operative assessment of vascular
involvement
Multiple comorbidities




rative bleed Portal vein reconstruction in elderly patient with
multiple comorbidities
injury Insufficient pre-operative assessment
Tumour involved hepatic artery
Hepatic cirrhosis




Comorbidities: obesity and immune deficiency
Likely benign cyst in older patient
ERCP and stent should have been considered
instead of PD
rative bleed Pancreatitis at time of PD, no suspicion of
malignancy
transhepatic cholangiogram.
ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
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HPB 1473five (6%) deaths. A summary of the ANZASM findings for these
patients is shown in Table 3. Two of these patients had a sig-
nificant vascular injury and a further two patients had locally
advanced disease, which would have made complete excision
highly improbable. In three of the six descriptions, the surgeon
completing the patient report had already determined that in
hindsight she/he would not have attempted to continue with the
resection. There was no overlap of patients who had an assess-
ment of a poor decision to operate or proceed (intraoperative
decision to continue).Major complications
Forty-two complications were considered significant clinical
events in 29/84 (35%) patients. These complications were cate-
gorised by the authors as ‘postoperative haemorrhage’ (Table 4),
‘vascular injury’ (Table 5) and ‘other complication’
(Supplementary Table 7). All but two of the twelve anastomotic
leaks were from the pancreatic anastomosis and were associated
with postoperative haemorrhage. Two of the patients whose
complications were considered to be recognised late suffered a
leak from the hepaticojejunostomy. The assessor determined that
there was a delay in recognising a significant complication in 18/
84 (21%) of patient deaths. These complications are summarised
in Table 6.
Vascular injury was determined by the ANZASM assessors to
be a significant intraoperative clinical event in eight (10%) pa-
tients. Three patients were noted to have aberrant anatomy. One
vascular injury was discovered postoperatively; this was a pseu-
doaneurysm of the hepatic artery discovered on day two. All
injuries identified intraoperatively resulted in the primary sur-
geon requesting and receiving assistance from either another
hepatobiliary surgeon or vascular surgeon. ANZASM assessors
questioned the decision to proceed after the injury in two pa-
tients and the decision to operate in another. The most common
course to death after vascular injury was successful initial control
of bleeding, followed by delayed ischemia of either the bowel or
liver resulting in multi-organ failure.Table 3 Patients in whom ANZASM Assessor’s determined a flawed d







15 74 Elective Yes N
16 68 Elective Yes D
17 65 Elective Yes N
18 61 Elective Yes V
19 69 Elective Yes V
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This study sought to quantify and thematically describe the
significant clinical issues around peer-reviewed audited deaths
post-PD in Australia. The ANZASM assessment process was
completed in 97% of patients who died in hospital after PD
across the study period. This cohort of patients represents a
crude mortality rate of 3.7%, which is consistent with the 3%
reported in a recent Australian study inpatient deaths after PD.1
The frequency of second-line assessment seen in the patients
who died after PD is double the average second-line assessment
rate in ANZASM, and likely reflects the complex and specialised
nature of PD and its complications. ANZASM concordance
analysis has shown agreement between first and second-line
assessment in around 70% of patient care reviews.14 When
looking at the documentation of each patient death, it is evident
that the process encourages thorough review of events by the
treating surgeon and ANZASM assessors. This reflection of
practice and the feedback provided by the assessors is likely to be
beneficial to the treating team and is also seen as an educational
opportunity for assessors. Assessors collect continuing profes-
sional development points in recognition of their voluntary
participation.
Preoperative decision making is crucial both to prevent un-
helpful surgery and to provide the best care to those that are
resectable. While the benefit of hindsight may be a confounding
factor, assessors were of the opinion that the decision to operate
was flawed in 17% of patient deaths. Retrospective examination
of the individual patient reports revealed significant comorbid-
ities overlooked, insufficient radiological imaging or proceeding
despite radiologically identified vascular involvement or known
metastatic disease. While the actual number of deaths is low, the
relative incidence of the finding of a poor decision to operate did
not improve through the study period and there were four such
events in the 2016–2017 financial year. There is considerable
evidence in the literature for routine preoperative multidisci-
plinary team (MDT) discussion for optimal decision making








Combined with hepatic resection.
Intraoperative finding of mesenteric vein
involvement more than expected
o Intraoperative finding of locally advanced
disease
ascular injury Injury to hepatic artery, very long operative
time
ascular injury Intraoperative injury to coeliac trunk when
releasing media arcuate ligament
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Table 4 Patients who suffered a postoperative haemorrhage





Nature of bleed ANZASM assessor’s comment
4 57 Decision to operate Elective PD for malignancy in setting of
pancreatitis and death from post-operative
haemorrhage less than 24 h later
The decision to attempt a pancreatic resection on
this patient was a mistake due to peri-operative
pancreatitis.
6 75 Decision to operate POPF and secondary haemorrhage requiring re-
operation. Patient was accidentally fully
anticoagulated
Aggressive operation with portal vein
reconstruction in elderly patient with advanced
disease. Unsatisfactory medical management.
14 52 Post-operative bleed Catastrophic secondary haemorrhage on POD9
post discharge from hospital
Pancreatitis at time of PD, no suspicion of
malignancy
20 72 Anastomotic leak POPF and secondary haemorrhage POD8 with
GDA stump bleed seen at laparotomy. Post
second operation, small bowel and hepatic
ischemia
POPF and secondary haemorrhage
21 79 Delay in recognising
complication
anastomotic leak
POPF and bleed from GDA pseudoaneurysm
POD6. Failed embolisation. Proceed to
laparotomy where portal vein was injured.
Late recognition of POPF and secondary
haemorrhage. Questioned management of
bleeding post-embolisation
22 76 Anastomotic leak Transferred from another hospital after failed re-
operation to control post-operative
haemorrhage. Underwent embolisation and
further re-operation to revise anastomoses
Referral hospital unsuccessful in management of
pancreatic fistula
23 64 Anastomotic leak Laparotomy for bleeding on POD1. Portal vein
branches actively bleeding and oversewn.
POD6 and POD7 laparotomy for bleeding. GDA
stump bleed found and oversewn. Further
bleeding. No interventional radiology available
at hospital
Post-operative bleeding
24 73 Anastomotic leak Contrast imaging showed bleeding from GDA in
setting of POPF. Laparotomy confirmed
bleeding from GDA and SMA with ischemic
bowel.
POPF and secondary haemorrhage
25 59 Other complication Returned to theatre POD6 for debridement of
abscess in anterior abdominal wall. Intra-
abdominal haemorrhage and laparotomy on
the following day revealed GDA stump bleed
Bleed from gastro-duodenal artery
26 62 Delay in recognising
complication
anastomotic leak
POPF and secondary haemorrhage. Investigated
and unsuccessfully treated with gastroscopy
and laparotomy. Source not seen
radiologically. Eventual catastrophic
haemorrhage
Delayed recognition of POPF. Surgeon operating
without sub-specialist training
27 55 No Catastrophic haemorrhage post-operative day
(POD) 8. At emergency laparotomy, right
gastric artery ligated
Questioned method used to secure right gastric
artery at PD; technical cause of delayed
haemorrhage (method not noted in comment)
28 77 Vascular injury Right hepatic artery accidentally divided and
repaired during PD. Emergency laparotomy
POD10 revealed bleeding behind the hepatico-
jejunostomy and an ischemic right colon.
Subsequent hepatic ischemia.
Poor management of the deteriorating patient
and documentation of events.
29 67 Anastomotic leak Known POPF and secondary haemorrhage
POD6. At emergency laparotomy, bleeding
from branch of SMA
POPF and secondary haemorrhage
30 69 Delay in recognising
complication
anastomotic leak
Delayed gastric emptying and CT evidence of
POPF for a week prior to massive
haematemesis.
Delay in investigating the patient with delayed
gastric emptying and evidence of POPF
31 70 Delay in recognising
complication
Laparoscopic PD complicated by port site hernia
and POPF. Laparotomy POD9 found bleeding
from GDA stump. Portal vein narrowed on
subsequent scans.
Post-operative care in managing POPF was
unsatisfactory
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Table 4 (continued )





Nature of bleed ANZASM assessor’s comment
32 69 Anastomotic leak POPF and secondary haemorrhage from
pseudoaneurysm of the common hepatic
artery. This was embolised with subsequent
hepatic ischemia.
Haemorrhage secondary to POPF
33 77 Delay in recognising
complication
anastomotic leak
POPF and secondary haemorrhage POD18.
Required transfusion on the three days prior
with normal CT angiogram. Subsequent formal
angiogram showed bleeding pseudoaneurysm
that was embolised.
Suggested earlier consideration of interventional
angiography (agreed with surgeon’s self-
assessment)
POD, postoperative day; GDA, gastroduodenal artery; POPF, post-operative pancreatic fistula.
HPB 1475determine whether preoperative MDT discussions took place.
However, logic would suggest that a group discussion could have
prevented at least a proportion of the deaths considered as
subsequent to a poor decision to operate. In addition, predictive
algorithms such as the ACS-NSQIP ‘Pancreatectomy Risk
Calculator’17 may assist in quantifying risk when making the
decision to operate.
The most common cause of death after vascular injury was
ischemia of either the bowel or liver resulting in multi-organ
failure. Ischemic complications are important considerations
after PD and can be due to pre-existing arterial stenoses or
inadvertent arterial injury.18 While meticulous dissection can
minimise complications, peripancreatic inflammation or inva-
sion may obliterate dissection planes and distort anatomy.19 It is
crucial that aberrant arterial anatomy is identified prior to sur-
gery to ensure unusual anatomy under difficult circumstances is
anticipated. Porto-mesenteric venous resection with the aim of
achieving an R0 resection has not been shown to worsen peri-
operative outcome20 and did not present as an issue with this
cohort of patients.Table 5 Patients who suffered an intraoperative vascular injury







7 63 Elective Yes D
18 61 Elective Yes D
19 69 Elective Yes D
28 77 Elective Yes P
34 65 Elective Yes N
35 75 Elective Yes N
36 67 Elective Yes N
37 63 Elective Yes N
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plications in almost a quarter of deaths is a significant finding
that warrants consideration for clinicians involved in the post-
operative care of PD patients. The concept of failure to rescue
(FTR) is defined as the death of a patient due to a major post-
operative complication.21 Nationwide studies from the United
States, Germany and the Dutch Pancreatic Cancer Audit (DPCA)
into PD outcomes have suggested that varying mortality rates
can be explained by variations in FTR rather than major
complication rates.5,6,22 FTR rates in the DPCA were calculated
as the number of deaths after major complication divided by the
number of major complications and found to be 14%.5 While an
FTR rate cannot be calculated from the ANZASM figures, the
earlier recognition of complications would go further to
reducing FTR and subsequent inpatient mortality in Australia.
Participation in the ANZASM peer review and feedback pro-
cess has increased nationwide across the duration of this study
and over this time a decrease in the overall surgical postoperative
mortality rate (POMR) has been well documented.7 Relevant to
PD was the centralisation of the procedure in Western Australiadditional
ignificant event
Nature of injury
ecision to operate Portal vein injury with massive intra-
operative haemorrhage
ecision to proceed Hepatic artery injury in setting of aberrant
anatomy
ecision to proceed Intraoperative injury to coeliac trunk when
releasing media arcuate ligament
ost-operative
haemorrhage
Right hepatic artery accidentally divided.
Aberrant anatomy.
o Division of superior mesenteric artery
o Portal vein injury with massive intra-
operative haemorrhage
o Division of superior mesenteric artery
o Portal vein injury with massive intra-
operative haemorrhage
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Table 6 Patients who had a complication where there was a delay in its recognition, and subsequent rescue was unsuccessful as a result








5 52 Elective Yes Decision to operate Multiple comorbidities
11 70 Elective Yes Decision to operate Transfer to a larger hospital should have occurred before
complication became too difficult to manage
16 68 Elective Yes Decision to proceed Combined with hepatic resection. Intraoperative finding of
mesenteric vein involvement more than expected
21 79 Elective Yes Post-operative haemorrhage Late recognition of POPF and secondary haemorrhage.
Questioned management of bleeding post-embolisation
26 62 Emergency Yes Post-operative haemorrhage Delayed recognition of POPF. Surgeon operating without sub-
specialist training
30 69 Elective Yes Post-operative haemorrhage Delay in investigating the patient with delayed gastric emptying
and evidence of POPF
31 70 Elective Yes Post-operative haemorrhage Post-operative care in managing POPF was unsatisfactory
33 77 Elective Yes Post-operative haemorrhage POPF and secondary haemorrhage. Suggested earlier
consideration of interventional angiography
39 74 Elective Yes Other complication SMV thrombosis and ischemic small bowel
42 73 Emergency Yes No Delay in recognising POPF. Clinical changes on POD4/5 could
have been considered more seriously
43 77 Elective Yes No Delayed gastric emptying without nasogastric decompression
that resulted in aspiration. Unsatisfactory analgesia
44 70 Emergency Yes No Failure to aggressively investigate haematemasis and
hypotension when patient re-presented to hospital on POD17
45 65 Elective Yes No Delay in relook laparotomy with findings of POPF and colonic
ischemia
46 83 Elective Yes No Delayed gastric emptying without nasogastric decompression
that resulted in aspiration
47 79 Emergency Yes No Admission to ICU with intra-abdominal sepsis and multi-organ
failure without mention of any action taken to treat
48 73 Elective Yes POPF Leak from hepatico-jejunostomy that was recognised late
49 66 Elective Yes No Nasogastric tube not in place despite vomiting
50 81 Elective Yes POPF Leak from hepatico-jejunostomy and POPF
POPF, post-operative pancreatic fistula; POD, postoperative day.
1476 HPBafter a review using ANZASM data.23 A more recent review of
nationwide data shown a reduction in PD POMR since partici-
pation in ANZASM has increased.1 While there will likely always
be a significant risk of mortality as a result of a complex pro-
cedure such as PD, the ANZASM formalises the reflection that
surgeons and their teams undertake after each death and pro-
vides objective feedback. It can be seen from the data presented
here, that the reasons for mortality post-PD have not changed
significantly. While an individual death is likely to be well
considered within the relevant surgical unit, review of a large
number of PD mortalities has not been available. This paper is
unique in its examination of the clinical events leading to mor-
tality for PD and is the first to examine the ANZASM assessors’
findings of the significant clinical events prior to mortality for a
specific procedure.
The limitations of this study include consideration of a high
majority (97% of hospital reported deaths), but not everyHPB 2019, 21, 1470–1477 © 2019 International Hepato-P
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to second line assessment (with full patient note review), the
details surrounding each patient’s death are those provided by
the treating surgeon themselves. The assessors make an indi-
vidual and subjective assessment of the events leading to each
patient’s death and consistency across assessments cannot be
assured. The ANZASM does not include procedural volume
and therefore little can be said about the POMR from this data.
While this could be crudely extrapolated by combining
ANZASM data with national Medicare data, POMR has been
more comprehensively analysed elsewhere.1 ANZASM asses-
sors did not describe a significant adverse event in a some
patient deaths where there were issues with post-operative
care. To maintain consistency, these patients were not
included in the reported results. However, these patient reports
were re-examined by the authors and the details included as
supplementary data.ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
urgeons from ClinicalKey.com.au by Elsevier on January 01, 2020.
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HPB 1477The factors under a surgeon’s control that can impact the
success, or otherwise, of an operative intervention include the
decision to operate in the first place, the quality of the operation
performed and the postoperative care. For PD, a highly complex
procedure with significant morbidity, these factors become
magnified. This study has sought to summarise the significant
clinical events leading to mortality after PD in Australia. The
large proportion of patients where the decision to operate or
proceed was questioned by assessors was a concerning feature. In
addition, the finding of nearly a quarter of deaths being assessed
to be associated with late recognition of complications warrants
consideration for Australian surgeons involved in PD.
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Background: The data within the Australian and New Zealand Audit of Surgical Mortality (ANZASM)
provides a unique opportunity to consider the contributing factors to perioperative deaths as determined
by peer review. Consideration of the factors contributing to mortality after hepatectomy can provide
greater insight into how deaths can be prevented. The objective of this study was to determine the
reasons for patient deaths post-hepatectomy in Australia.
Methods: ANZASM data from 1 January 2010 to 30 Jun 2017 was reviewed and all deaths following
hepatectomy were selected for analysis. Assessors determinations of whether management could have
been improved were reviewed, and then classified into groups of significant clinical events using the-
matic analysis with a data driven approach.
Results: The study included 88 deaths reported to ANZASM after hepatectomy. The assessors
questioned the decision to operate in 23/88 (25%) patients with a further nine (10%) patients insuffi-
ciently investigated prior to resection. ANZASM assessors determined that there was a delay in
recognising a significant complication in 16/88 (18%) patients.
Conclusion: Multi-disciplinary decision making is strongly recommended when deciding which patients
to treat with hepatic resection. Optimal care post-hepatectomy includes early recognition of complica-
tions and enactment of an adequate rescue plan.Received 6 July 2019; accepted 2 September 2019Correspondence
Claire L Stevens, Discipline of Surgery, University of Adelaide, Australia. E-mail: Claire.stevens@sa.gov.auIntroduction
The Australian and New Zealand Audit of Surgical Mortality
(ANZASM) is a peer review audit of surgical deaths under the
direction of the Royal Australasian College of Surgeons (RACS).
The objective of the audit is to improve the quality of surgical
practice through information gathering and feedback, education
and facilitation of change. The audit has been conducted
Australia-wide since 2010 and has collected considerable data on
surgeon identified avoidable issues contributing to in-hospital
surgical deaths. While ANZASM was formed to serve both na-
tions, New Zealand does not currently participate in the
ANZASM program. In New Zealand, a Perioperative Mortality
Review Committee is responsible for reviewing and reporting
mortalities, with a view to reducing deaths and enabling
continuous quality improvement.No previous communication to society or meeting.
HPB xxxx, xxx, xxx © 2019 International Hepato-P
Please cite this article as: Stevens CL et al., Peer review of mortality after hepatIn Australian hospitals, hepatic resection (hepatectomy) has a
perioperative mortality rate of 1.6%.1 Despite being conducted
in relatively low volume centres, morbidity and mortality rates
for patients undergoing hepatectomy performed in Australia are
comparable to those seen internationally.1 International studies
have shown improved perioperative outcomes over time due to
better patient selection, improved anaesthetic and perioperative
management of patients, and higher proportions of parenchymal
sparing segmental resections.2,3 The hospital and surgeon
volume effect on outcomes has been extensively investigated with
recommendations such as threshold volumes,4,5 the presence of
organised multidisciplinary teams and optimisation of hospital
resources for complex surgical procedures.6,7 The ability to
“rescue” a patient after a major complication directly affects
mortality rates, which has been linked to both hospital resources8
and patient selection prior to surgery.9 Consideration of all these
factors are likely to lead to improved outcomes post-ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
ectomy in Australia, HPB, https://doi.org/10.1016/j.hpb.2019.09.001
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2 HPBhepatectomy. However, debate continues as to which aspects of
patient care are most likely to have the most impact on periop-
erative mortality.
The ANZASM provides a unique opportunity to investigate
the events leading to mortality post-hepatectomy in Australian
hospitals over recent years. This audit enables examination of the
preoperative, intraoperative and postoperative events leading to
each investigated death. The objective of this study was to
determine the reasons for patient deaths post-hepatectomy in
Australia.Methods
ANZASM data and peer review process
The function, governance and objectives of the ANZASM have
been thoroughly described elsewhere.10 However, a synopsis of
the audit process is described here.
Independent of the treating surgeon, ANZASM is notified of
in-hospital surgical deaths (whether there was a surgical pro-
cedure or not) by medical records departments. The hospi-
tal data includes designation of the admission as emergency
or elective, which is determined by whether the admission
was due to a planned procedure on a waiting list. Clinical de-
tails are collected via a standardised form completed by
the treating surgeon either online or in paper format. (The
ANZASM surgical case form is available at https://www.surgeons.
org/research-audit/surgical-mortality-audits/requests-for-anzasm-
data). ANZASM data is stored in an encrypted database that
enables a complete audit trail. The de-identified patient details
are sent for first-line assessment to a surgeon of the same
speciality from a different hospital. In most cases, conclusions
may be reached about the patient’s care at this point and further
investigation is deemed unnecessary. However, if further
consideration of the patient’s care is required, a second-line
assessment is conducted by a different surgeon. The second-
line assessor reviews the involved hospital’s patient notes.
Second-line assessment was undertaken in approximately 12% of
all patients referred to ANZASM during the study period.11
As a part of the audit process, ANZASM assessors determine
whether there was an aspect of the patient’s management that
could have been better, and feedback is provided to the treating
surgeon. The ANZASM data is held under qualified privilege
which protects the confidentiality of identifying information for
both practitioner and patient.12 This protection enables surgeons
to freely divulge information with confidence that the informa-
tion gathered will be used exclusively for the purposes of quality
assurance and professional development. Since 2012, 100% of
public hospitals, up to 92% of private hospitals and over 98% of
surgeons participate.11,13
Data analysis
Prospectively collected ANZASM data from 1 January 2010 to 30
Jun 2017 was retrospectively reviewed and deaths followingHPB xxxx, xxx, xxx © 2019 International Hepato-P
Please cite this article as: Stevens CL et al., Peer review of mortality after hepathepatectomy were selected for analysis. Deaths included are
inpatient deaths including those re-admitted after initial
discharge after hepatectomy. The authors excluded patients with
procedures of additional complexity outside of normal practice
or in an emergency setting for trauma or haemorrhage. De-
mographics, clinical and treatment details including the docu-
mentation of post-hepatectomy liver failure (PHLF) were
gathered from the information submitted by Australian hospitals
and treating surgeons. For each patient, the assessor’s determi-
nation of whether management could have been improved in the
areas of decision to operate, intraoperative and technical man-
agement of surgery and postoperative care were analysed.
As a part of the audit process, assessors determine significant
clinical events relevant to the patient’s care. The process is similar
for first and second-line assessment. Where a second-line or
patient note assessment was performed, this was used in the
analysis and the first line assessment disregarded. For all other
patients, the first line assessment findings were included. As-
sessors annotate whether each of the clinical events were firstly, a
contributing factor in the death of the patient and secondly,
preventable or not. The determination of preventability, while
relevant to each individual patient, was not considered further
here. Preventable and non-preventable clinical events leading to
mortality were all included in this study as they are useful in the
determination of causes for mortality as an outcome of
hepatectomy.
Assessor’s clinical issue descriptions were reviewed and clas-
sified into groups of significant clinical events using thematic
analysis with a data driven approach.14 Methods described by
Braun and Clarke were used to develop themes.15 Two re-
searchers (CS and JR) then independently classified the assessor’s
clinical issue descriptions into the relevant themes. Differences
were discussed, and consensus achieved.Results
From January 2010 to June 2017 there were 98 deaths reported to
the ANZASM after elective hepatectomy. Medicare Australia data
(which includes all patients, private and public) recorded 8587
HRs during this period.16 This cohort of patients from ANZASM
represent 1.1% of all hepatic resections. Ten (1.0%) patients were
excluded from the study due to procedures of emergent nature or
complexity of outside of normal practice. Three patients who
had combined pancreaticoduodenectomy and a further three
patients who had caval resection and/or veno-venous bypass
were included in this number.
Patient characteristics retrieved from the ANZASM patient
reports are summarised for 88 patients in Table 1. The median
age of the patients was 71 years (45–89 years). Clinically sig-
nificant infection was reported in 34/88 (39%) patients. Return
to theatre was reported in 35/88 (40%) patients. Postoperative
hepatic liver failure was documented as a complicating factor in
56/88 (64%) of patients.ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
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Table 1 Summary of patients
Number of patients (%)
American Society of Anaesthesiologists (ASA) Score
ASA 1 3 (3)
ASA 2 35 (40)
ASA 3 43 (49)
ASA 4 5 (6)





Colorectal metastases 28 (32)
Hepatocellular carcinoma 25 (28)
Cholangiocarcinoma 25 (28)
Gall bladder cancer 2 (2)
Bile duct stricture of uncertain aetiology 2 (2)
Polycystic liver disease 1 (1)
Other metastatic disease 5 (6)
Other metastatic disease: Melanoma, gastric adenocarcinoma, renal cell
carcinoma, neuroendocrine tumour, squamous cell carcinoma.
HPB 3ANZASM first-line peer review assessment was conducted in
all 88 of the reported deaths. Second-line assessment with full
review of the patient’s hospital documentation was conducted for
25% (22/88) of these patients. Sixty-nine clinically significant
adverse events were described by the assessors in 58 patients,
with 11 patients having two adverse events described.
Tables documenting patient outcomes by the themes identified
by the assessors are shown in Tables 2–6 and Supplementary
Table 1. Each patient is labelled with an individual number
(patients 1–58) for purposes of tracking across the themes. In
the remaining 30 patients, there were no assessors’ comments on
clinically significant adverse events leading to the patient’s
mortality. For these 30 patients, the data submitted by the
treating surgeon was reviewed by the authors and a summary of
that record of events is included as Supplementary Table 2 (pa-
tients 59–88). The treating surgeon noted that there had been an
adverse event in three of these patients.Discussion
This study sought to quantify and thematically describe the
significant clinical issues around peer-reviewed audited deaths
post-hepatectomy in Australia. The ANZASM assessment pro-
cess was completed in all of the patients who died in hospital
after hepatectomy across the study period. This cohort of pa-
tients represents a crude mortality rate of 1.1%, which is
consistent with the 1.6% reported in a recent Australian study
examining inpatient deaths after hepatectomy.1HPB xxxx, xxx, xxx © 2019 International Hepato-P
Please cite this article as: Stevens CL et al., Peer review of mortality after hepatThe frequency of second-line assessment seen in the patients
who died after hepatectomy is double the average second-line
assessment rate in ANZASM. This is similar to the findings of
a study examining ANZASM assessment of mortality after
pancreaticoduodenectomy.17 The use of second line assessment
likely reflects the complex nature of care post hepatobiliary
surgery and its associated complications. When looking at the
documentation of each patient death, it is evident that the pro-
cess encourages thorough review of events by the treating sur-
geon and ANZASM assessors. This reflection of practice and the
feedback provided by the assessors is likely to be beneficial to the
treating team and is also seen as an educational opportunity for
assessors. Assessors collect continuing professional development
points in recognition of their voluntary participation.
Preoperative decision making for hepatectomy is complex and
requires consideration of multiple factors including overall pa-
tient health, tumour burden, functional volume (including
chemotherapy effects and/or the presence of cirrhosis), and
inflow and outflow preservation. Assessors were of the opinion
that the decision to operate was flawed in 25% of patient deaths
after hepatectomy. While the benefit of hindsight may be a
confounding factor in this assessment, the high proportion of
patient deaths that this represents is concerning. When the de-
cision to operate was questioned by the assessors, explanatory
comments commonly referred to the patient’s age and comor-
bidities. Increased mortality risk for older patients has been well
documented. However, hepatectomy is considered a reasonable
operation in the well selected octogenarian18,19 and a recent
Australian study has reported excellent results in age group.20 A
study using date from the American College of Surgeons Na-
tional Surgical Quality Improvement Database,9 has reported a
significantly higher mortality risk for borderline operative pa-
tients irrespective of the tumour resected. By their definition, a
combination of factors rendered an individual patient a
borderline operative candidate for hepatectomy including age
>75 years, pulmonary disease, cardiovascular disease, weight
loss, steroid use and or perioperative sepsis. These comorbid
patients were found to be more susceptible to postoperative
adverse events that were subsequently unable to be rescued.
Thorough preoperative patient assessment, medical optimisation
of borderline operative patients and the choice of appropriate
magnitude operations can improve surgical outcomes.9
Assessors’ explanatory comments for questioning the decision
to operate included instances where technical aspects of the type
of surgery were thought to need more careful consideration. Al-
ternatives to liver resection such as liver transplantation, ablative
techniques and other locoregional therapies may be a more
appropriate choice for some patients. International consensus
statements warn against combined major colon and major liver
resection21 and any combined surgery requires careful consider-
ation of risks to the patient. There is evidence in the literature
for routine preoperative multidisciplinary team (MDT) discus-
sion to consider these issues and optimise each patient’s treatmentancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
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Please cite this article as: Stevens CL et al., Peer review of mortality after hepatplan.5,7,22 ANZASM data is not sufficient to determine whether
preoperative MDT discussions took place. However, specialist
group discussion could likely have prevented at least a proportion
of the deaths considered as subsequent to a poor decision to
operate. The patients that had insufficient pre-operative assess-
ment would likely all have benefited from such a discussion.
Post-hepatectomy liver failure (PHLF) is the most serious
complication of hepatectomy, which has been shown to
contribute significantly to mortality. Of the patients in this study,
64% were documented as suffering this complication. This is
consistent with the 40–60% rate of PHLF reported elsewhere in
patients who died in the 90 days post-hepatectomy.23,24 However,
there was no consistent definition used by assessors or surgeons
in making this determination in patients’ audit documents. Risk
factors for PHLF are similar to those reported for overall mor-
tality,25 and include age >70 years, preoperative chemotherapy,
steatosis, major resection, vascular reconstruction and intra-
operative blood loss.23,26,27 The application of a surgeon’s un-
derstanding of these risk factors is vital to appropriate selection
and optimisation of patients for surgery and in the decision to
proceed when faced with unexpected intraoperative events.
The management of complications is an important determi-
nant of mortality4,28 and the surgical procedure itself is only a
part of the care model for patients undergoing hepatectomy.
ANZASM assessors concluded that late recognition, and there-
fore delayed action to treat complications, occurred in almost a
fifth of patient deaths. The concept of failure to rescue (FTR) is
defined as the death of a patient due to a major postoperative
complication.29 FTR has been linked to a relative lack of speci-
alised hospital resources,6 the analysis of which is beyond the
scope of this paper. The significant number of patients seen here
to have been subject to FTR warrants further investigation,
particularly in Australia where resources available in hospitals
performing hepatectomy vary, and hospital and surgeon volumes
are relatively low. The second influencing factor on the ability to
rescue after major complication is the comorbid state of the
patient.9 The need for careful patient selection has already been
discussed. Late recognition of complications can only be
magnified in a more fragile patient. The earlier recognition of
complications would go further to reducing FTR and subsequent
inpatient mortality.
Participation in the ANZASM peer review and feedback pro-
cess has increased nationwide across the duration of this study
and over this time a decrease in the overall surgical postoperative
mortality rate (POMR) has been well documented.10 However, a
recent review of nationwide data did not show a reduction in
hepatectomy POMR over time.1 That study concluded that more
work needed to be done to determine the reasons for regional
variability and the lack of improvement over time. Examining
the data presented here reveals no significant change in the
reasons for mortality post-hepatectomy over time. However, it
does highlight the need for improved decision making prior to
surgery and careful attention to perioperative care.ancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
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10 HPBWhile there will likely always be a significant risk of mortality
as a result of a complex procedure such as hepatectomy, the
ANZASM formalises the reflection that surgeons and their teams
undertake after each death and provides objective feedback. This
paper is unique in its nationwide examination of the clinical
events leading to mortality post-hepatectomy.
The limitations of this study include firstly that hepatic resection
is a variable procedure for different pathologies being performed
on an organ that may be diseased due to preoperative treatment or
cirrhosis. Aside from the patients that went to second line assess-
ment (with full patient note review), the details surrounding each
patient’s death are those provided by the treating surgeon them-
selves. The assessors make an individual and subjective assessment
of the events leading to each patient’s death and consistency across
assessments cannot be assured. The ANZASM does not include
procedural volume and therefore little can be said about the POMR
from this data. While this could be crudely extrapolated by
combining ANZASMdatawith national Medicare data, POMR has
been more comprehensively analysed elsewhere.1 ANZASM as-
sessors did not describe a significant adverse event in a some pa-
tient deaths where there were issues with postoperative care. To
maintain consistency, these patients were not included in the re-
ported results. However, these patient reports were re-examined by
the authors and the details included as supplementary data.
The factors under a surgeon’s control that can impact the
success, or otherwise, of an operative intervention include the
initial decision to operate, preoperative preparation of the patient
and their liver, the quality of the operation performed and the
postoperative care. For hepatectomy, a complex procedure with
significant risk of morbidity, these factors become magnified.
This study has sought to summarise the significant clinical
events leading to mortality after hepatectomy in Australia. The
large proportion of patients where the decision to operate was
questioned by assessors was a concerning feature of this study’s
result. In addition, the finding of a nearly a fifth of deaths being
associated with late recognition of complications warrants
consideration for Australian surgeons involved in hepatectomy.
The authors recommend participation in multidisciplinary dis-
cussion prior to hepatectomy, particularly in the case of major
resections on comorbid patients. Perioperative care is as
important as the operative procedure itself and warrants careful
attention to detail, such that complications are detected early and
the patient can be appropriately rescued.
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Abstract
Background: Pancreaticoduodenectomy (PD) is a high-risk procedure. Australian hospitals
perform a relatively low volume of PD. This study sought to gain an understanding of hos-
pital volume and short-term outcomes of the procedure in the Australian state of Victoria.
Methods: The Dr Foster Quality Investigator tool was used to interrogate the Victorian
Admitted Episodes Database for the Australian Classification of Health Intervention code
for PD (30584) from July 2010 to June 2016. The data set included patients from a peer
group of 14 hospitals that included all the public hospitals performing PD during this
period. Patient characteristics, inpatient mortality, 30-day readmission rates and median
length of stay were reported for each de-identified hospital.
Results: There were 547 PD conducted over 6 years in 10 public hospitals. The median
patient age was 65 years. Inpatient mortality was 2.7%. There was a significant risk adjusted
difference in mortality between principal referral and other public hospitals. Annual hospital
volume ranged from 3 to 20 PD, and there was no significant relationship between mortal-
ity, readmission rates or length of stay and hospital volume.
Conclusion: The inpatient mortality associated with PD in Victorian public hospitals is
comparable to that seen in overseas studies. While hospital volume is relatively low, there
does not seem to be a relationship between volume and short-term outcomes. Variability
between hospital peer groups suggests that resource availability is more important than vol-
ume. The development of a procedure specific registry would be useful to test the outcomes
of this study and determine long-term PD outcomes.
Introduction
Pancreaticoduodenectomy (PD) is a complex specialized procedure
with a significant peri-operative mortality rate. Australian hospitals
have morbidity and mortality rates comparable to international
reported values, despite relatively low surgeon and hospital
volumes.1–3 A recent study examining Australian Institute of Wel-
fare data found an inpatient mortality of 3.6% following PD in Vic-
toria and 3% Australia-wide, with improvement over time and
significant inter-state variability.4
The last 10 years has seen centralisation of major pancreatic sur-
gery in the USA, UK and the Netherlands5–7 with subsequent ana-
lyses confirming the positive effect of a concentrated volume. The
incidence of pancreatic and periampullary cancers in Australia is
comparable with that of the USA and Europe.8 However,
Australia’s population is significantly smaller and more widely dis-
persed. In the state of Victoria, there are 10 public and a smaller
number of private hospitals where PD is performed to treat a popu-
lation of 6.4 million9 undergoing around 100 PD per year.10
Dr Foster Quality Investigator (DFQI) is a quality measurement
tool that was in use by the Department of Health in the Australian
state of Victoria from 2014 to 2017. The system allows the user to
access administrative data to investigate mortality rates and other
indicators of quality such as readmission rates and length of stay
(LOS). Data can be compared with consideration of influencing
factors such as patient demographics and diagnoses. The aim of
this study was to determine the inpatient mortality rate,
readmission rate and LOS for PD in Victorian public hospitals
with assessment of individual hospital variation using the
DFQI tool.




The DFQI tool was used to interrogate the Victorian Admitted
Episodes Database for the Australian Classification of Health
Intervention code for PD (30584). The data set included patients
from of 14 public hospitals that had agreed to participate in a peer
group for comparison of outcomes under the framework of the
DFQI tool. All the public hospitals performing PD during the
financial years 2010/2011 to 2015/2016 were a part of this peer
group.
Patient characteristics, inpatient mortality, 30-day readmission
rates and average LOS were reported for each de-identified hospi-
tal. Demographic information included age, gender and comorbid-
ity burden. Comorbidities were those entered on discharge from
hospital and included the relevant 31 Elixhauser comorbidities11
with the addition of dementia. Mortality was defined as inpatient
death. There was no data linkage to enable determination of
30-day mortality and as the data is de-identified, deaths in the
community (outside of a Victorian hospital) were not available for
inclusion. Readmissions were those to any hospital in Victoria
within 30 days from discharge, and they were allocated to the hos-
pital that performed the PD. The DFQI tool is operated under a set
of business rules which describe these definitions.12 Transferred
patients were recorded against the hospital in which they had
their PD.
Australian hospitals are classified into peer groups for the anal-
ysis and interpretation of hospital statistics and performance infor-
mation. Hospitals that share similar characteristics are grouped
together, providing a basis for meaningful comparisons.13 Of the
hospitals included in this study, all are acute public hospitals. Six
of the hospitals are principal referral hospitals (PRHs) and the
other four are public acute group A (PGA) hospitals. PRHs are
public acute hospitals that provide a very broad range of services,
have a range of highly specialized service units, and have very
large patient volumes. The term ‘referral’ recognizes that these
hospitals have specialist facilities not typically found in smaller
hospitals. PGA hospitals are public acute hospitals that provide a
wide range of services typically including a 24-h emergency
department, intensive care unit, coronary care unit and oncology
unit, but do not provide the breadth of services provided by
PRH.13 The difference between the two hospital subgroups
includes the level of intensive care facilities, availability of spe-
cialty care and the inclusion of bone marrow and/or organ trans-
plant services Inpatient mortality for PD was compared between
the two hospital peer groups and between individual hospitals by
volume.
For mortality rates, risk adjustment was performed using logis-
tic regression to provide a fair comparison between patient
cohorts in the Victorian Admitted Episodes Database. This analy-
sis was made within the DFQI tool. Patient factors used in risk
adjustments included age, gender, comorbidity burden, emergency
admissions in the previous 12 months, admission source and
month of admission. The risk modelling benchmark year was July
2013 to June 2014. Statistical analysis of proportions was per-
formed using chi-squared and Fisher’s tests with XLSTAT 2017
(Data Analysis and statistical solution for Microsoft Excel;
Addinsoft, Paris, France). P values less than 0.05 were considered
statistically significant.
This project was endorsed by the Dr Foster Intelligence Focus
Group Steering Committee and approved by the Barwon Health
Research Ethics, Governance and Integrity Unit.
Results
There were 547 PD over 6 years in 10 hospitals with an inpatient
mortality of 2.7% (15/547). The median patient age was 64.8 years
(15–85 years). The demographic characteristics of the patients who
underwent PD are summarized in Table 1.
The median number of PD per year per hospital was eight
(3.2–20.0). The overall volume remained steady over the study
period. The same 10 hospitals performed at least one PD in each of
the studied years. Figure 1 is a funnel plot of inpatient mortality by
hospital volume.
The median LOS was 15 days (12–21 days) and there was no
significant variation between hospitals. The cumulative deaths
by postoperative day are shown in Figure 2. About 86.7%
(13/15) deaths occurred within 30 days; 13.5% (74/547) patients
were readmitted to a Victorian hospital at least once within
30 days from discharge. Figure 3 is a funnel plot of number
of readmissions per year by annual hospital volume. No
readmitted patient died. Readmission rates were similar amongst
hospitals.
Table 1 Patient characteristics and mortality for pancreaticoduodenectomy






Number of patients 547 15 2.7
Age, years
0–17 2 (0%) 0 0
18–29 5 (1%) 0 0
30–49 45 (8%) 0 0
50–64 198 (36%) 4 2.0
65–74 192 (35%) 9 4.7
75–84 104 (19%) 2 1.9
>85 1 (0%) 0 0 0.442
Sex
Male 320 (59%) 10 3.1
Female 227 (41%) 5 2.2 0.603
Admission year
2010/2011 81 (15%) 3 3.7
2011/2012 104 (19%) 3 2.9
2012/2013 89 (16%) 2 2.3
2013/2014 85 (16%) 3 3.5
2014/2015 95 (17%) 2 2.1
2015/2016 93 (17%) 2 2.2 0.974
Pathology (discharge
diagnosis)
Malignant 455 (83%) 15 3.3
Benign 92 (17%) 0 0 0.051
Comorbidities
Lung disease 5 (1%) 1 20.0
Diabetes 98 (18%) 6 6.1
Renal disease 23 (4%) 2 8.7 0.262
Zero comorbidities 208 (38%) 2 1.0
>3 comorbidities 281 (51%) 11 3.9 0.050
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Outcomes for the seven PRHs are compared with the four PGA
hospitals in Table 2. The inpatient mortality rate for PRH was
1.7%, significantly lower than that for PGA hospitals at 4.8%
(P = 0.039). One of the PGA hospitals was a significant outlier
(Fig. 3) and another had a mortality rate of zero. Excluding the
poorer performing outlier reduces the inpatient mortality for PGA
hospitals to 2.8% and renders the statistical difference between the
two hospital groups as insignificant (P = 0.478).
Discussion
This study has examined a state-wide data set that has included
all PD performed in public hospitals in the state of Victoria over
a 6-year period. The overall crude inpatient mortality rate was
2.7% which compares favourably with that seen internationally
with inpatient mortality levels reported as 3–10%.5,14 While
mortality varied between individual hospitals (without statistical
significance due to low numbers), there was no relationship
between mortality and hospital volume. However, mortality was
significantly higher in PGA hospitals than PRH and this was
consistent after risk adjustment. A study using Victorian cancer
registry data from 2002 to 2003 reported 75 patients treated with
PD having a 30-day mortality rate of 5.3%.15 However, there
has been no published examination of state-wide mortality since
that study.
The relationship between volume and outcome for PD has
been widely discussed in the literature. Guidelines on hospital
volume have been put in place in the Netherlands,5 Canada16
and Germany17 and the definition of a high volume hospital con-
tinues to evolve.18 Centralisation and increasing hospital vol-
umes have been shown to improve post-operative and long-term
survival for PD.5,18 However, a suggested explanation is that
improvement in mortality could be related to an increased ability
to rescue from death after major complications.6,19,20 The data
presented here show a Victorian median public hospital volume
of eight PD per year with the highest volume hospital per-
forming 20 PD per year. By most definitions, these are not high
volume centres and yet the mortality results are comparable to
internationally reported values. Similar to the results seen here,
a study into Queensland and New South Wales Cancer Registry
data also found no relationship between hospital volume and
mortality or survival rates.21
The consideration of volume criteria alone can fail to identify
high-quality centres as there are other factors that contribute to
good outcomes.22 There is evidence to explain that paradoxically
good outcomes for PD in lower volume hospitals may be due to
those hospitals having excellent clinical resources.23 Resource
availability can also be a factor in the concept of failure to rescue;
defined as the death of a patient due to a major post-operative com-
plication.24 A recent study into the Australian and New Zealand
Audit of Surgical Mortality (ANZASM) findings for patient deaths
after PD revealed that there was a delay in the recognition and treat-
ment of complications in almost a quarter of patients.25 Hospitals
with greater resources and more complex institutional experience
would likely recognize and rescue the struggling patient earlier than
Fig. 1. Funnel plot showing variation in %
POMR post-pancreaticoduodenectomy in Victo-
rian public hospitals. ( ) %POMR; ( ) overall
mean mortality; ( ) 95% confidence limit;
PRH, principal referral hospital; PGA, public
group A hospital.
Fig. 2. Cumulative number of deaths post-pancreaticoduodenectomy by
postoperative day.
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those used to managing less complex patients with more limited
resources. A combination of these factors may account for the sig-
nificant difference seen in Victorian mortality rates between the
PRH and PGA hospitals.
Surgeon volume has been shown to account for a part of the
hospital effect in PD.26–28 A significant proportion of the surgeons
who performed the PD in this study’s dataset operate in two or
more of the hospitals examined. These inter-hospital links com-
monly extend between a PRH and PGA hospital. In addition,
approximately one-third of Australia’s PD is undertaken in private
hospitals, accounting for additional surgeon volume.4 It is likely
that the difference in mortality between the hospital peer group
types is independent of the operating surgeon.
LOS post-PD was similar between hospital peer groups and indi-
vidual hospitals. The median of 15 days (range 12–21 days) was
similar to that reported in other Australian studies1,2,29 and the
9–21 days reported for high volume hospitals in Germany19 and the
USA.19,30
The overall 30-day readmission rate of 13.5% compares
favourably with international rates of 15–38%.30 A recent study by
Sutton and colleagues investigating the links between volume and
readmission rates after PD for over 9000 patients in the USA found
that lower volume hospitals experienced higher readmission rates.
They also found that readmitted patients had a longer LOS for their
index admission. The relationship between hospital volume and
readmission rates was not seen in Victoria.
The data set studied precludes detailed assessment of patient
selection and its influence on the findings of inpatient mortality var-
iation between hospital peer groups. However, it should be noted
that patient selection has a significant impact on patient outcome on
pancreatic surgery. Multi-disciplinary decision making has been
strongly recommended by a recent study into Australian patient
deaths post PD.25 Each of the 10 public hospitals examined here
coordinate a regular dedicated hepatobiliary and upper gastrointesti-
nal multi-disciplinary meeting at which surgeons and oncologists
discuss patients from both public and private practices.
Patients older than 75 years of age made up 19.2% of the state-
wide public patient cohort. The inpatient mortality of these patients
was not significantly different to the younger patients (P = 0.559).
The low mortality rate in the older age group is suggestive of care-
ful patient selection in this cohort.
The good overall results shown here suggest that the state of Victo-
ria is achieving excellent short-term results for PD by international
standards. However, further investigations into the reasons for hospital
peer group variability are needed to determine whether improvements
to patient outcomes can be made. A recent study into Australia-wide
PD mortality including private and public hospitals found significant
interstate variability but could not provide risk-adjustment to aid in its
explanation.4 This study has shown using risk adjusted data that within
one of the Australian states, hospital peer group and, therefore,
resource availability may account for a variation in mortality.
The major limitation of this study has been that it considers only
inpatient mortality. The inability to derive a 90-day mortality rate
Fig. 3. Funnel plot showing variation in the
number of readmissions per year post-
pancreaticoduodenectomy in Victorian public
hospitals. ( ) %readmissions; ( ) overall
mean readmission rate; ( ) 95% confidence
limit.
Table 2 Summary of crude outcomes for pancreaticoduodenectomy by






Number of PD 547 361 186
Mean age
(range)
64 (15–85) 64 (15–85) 66 (19–83)







15 15 (12–19) 15 (15–21)
Inpatient
deaths* (%)
15 (2.7) 6 (1.7) 9 (4.8)
Relative risk
mortality




74 (13.5) 47 (13.0) 27 (14.5)
*P < 0.05. PD, pancreaticoduodenectomy.
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from the dataset prevents assessment of the full outcomes of such a
complex procedure with a long recovery time. An administrative
dataset that does not adjust for risks specific to PD such as pathol-
ogy, extent of resection and operative risk factors such as pancre-
atic consistency or duct size is limited. The quality of pancreatic
resection lies also in the oncological outcomes which are not
recorded at a population level in Victoria.
Despite its limitations, the results of this study confirm that inpa-
tient mortality for PD in the Australian state of Victoria is similar to
that reported internationally. The significant risk adjusted variation
in inpatient mortality between hospital peer groups warrants further
investigation. The development of a registry of pancreatic re-
section data would enable further study and potentially reveal areas
where some centres excel and others fail, thereby generating overall
improvement. In particular, patient selection, resource availability
and the use of appropriate rescue where necessary and would only
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Conclusions and Recommendations 
 
The inpatient mortality associated with hepatic resection in Australia is comparable to that 
seen overseas. However, there is significant variability between states without significant 
improvement over time. 
 
Contributing factors to death post PD and hepatic resection were seen to be similar. Multi-
disciplinary decision making has been strongly recommended in deciding which patients to 
offer these complex procedures with high rates of complication. Optimal care post PD and 
hepatectomy includes early recognition of complications and enactment of an adequate 
rescue plan.  
 
In the Australian state of Victoria, the finding of variability in mortality rates post PD 
between hospital peer groups and not hospital volume highlights the importance of 
resource availability in the care of these patients.  
 
The results seen in this group of studies should drive further investigation into the quality 
and variability of hepatic and pancreatic surgery in Australia. The development of a 
national registry would enable further investigation into the contributing factors to 
mortality, its regional variation and the optimal resource allocation strategy to prevent and 
rescue patients from complications.  
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